Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 75 entries
View as:

Efficacy and Safety of Fentanyl Buccal Tablets Compared With Oxycodone for the Management of Break Through Pain

Phase: N/A Priority: Normal
NCT ID: NCT00463047 Org: User:
Start: 07/31/07 End: 02/28/09 Due: 02/28/10

Efficacy and Safety of Oral CEP-701 for the Treatment of Patients With Advanced Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT00242827 Org: User:
Start: 04/30/06 End: 05/31/07 Due: 05/31/08

Study to Evaluate the Efficacy and Safety of Armodafinil as Adjunctive Therapy in Adults With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT00772005 Org: User:
Start: 09/30/08 End: 05/31/10 Due: 05/31/11

Study of Bendamustine Combined With Bortezomib for Patients With Relapsed/Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT00920855 Org: User:
Start: 06/30/09 End: 12/31/11 Due: 12/31/12

Safety/Efficacy Study With Armodafinil (CEP-10953) in Treatment of Excessive Sleepiness Associated With Chronic SWSD

Phase: N/A Priority: Normal
NCT ID: NCT00080288 Org: User:
Start: 03/31/04 End: 12/31/04 Due: 12/31/05

Extension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Phase: N/A Priority: Normal
NCT ID: NCT01121536 Org: User:
Start: 04/30/10 End: 10/31/13 Due: 10/31/14

Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT00105287 Org: User:
Start: 01/31/05 End: 09/30/07 Due: 09/30/08

Cytarabine in Combination With Arsenic Trioxide vs. Cytarabine Alone in Elderly Patients With Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00513305 Org: User:
Start: 10/31/07 End: 12/31/09 Due: 12/31/10

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Phase: N/A Priority: Normal
NCT ID: NCT01305408 Org: User:
Start: 03/31/11 End: 07/31/13 Due: 07/31/14

Study to Assess Satisfaction With Modafinil Treatment in Children and Adolescents With ADHD

Phase: N/A Priority: Normal
NCT ID: NCT00228540 Org: User:
Start: 09/30/05 End: 09/30/06 Due: 09/30/07

SDX-105 in Combination With Rituxan for Patients With Relapsed Indolent or Mantle Cell Non-Hodgkin's Lymphoma (NHL)

Phase: N/A Priority: Normal
NCT ID: NCT00076349 Org: User:
Start: 04/30/04 End: 03/31/08 Due: 03/31/09

Effentora® in Clinical Practice - a Non-interventional Study to Evaluate Satisfaction and Tolerability

Phase: N/A Priority: Normal
NCT ID: NCT01400854 Org: User:
Start: 07/31/11 End: 10/31/12 Due: 10/31/13

Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00481195 Org: User:
Start: 06/30/07 End: 12/31/08 Due: 12/31/09

Armodafinil (CEP-10953) in Treatment of Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea (OSA/H) Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00079677 Org: User:
Start: 03/31/04 End: 10/31/04 Due: 10/31/05

Study to Evaluate the Efficacy and Safety of OraVescent Fentanyl Citrate Treatment for the Management of Breakthrough Pain in Opioid-Tolerant Patients With Noncancer-Related Chronic Pain

Phase: N/A Priority: Normal
NCT ID: NCT00343733 Org: User:
Start: 08/31/06 End: 07/31/07 Due: 07/31/08

Study to Evaluate the Efficacy of Modafinil Treatment in Patients With Attention Deficit Hyperactivity Disorder (ADHD) Who Are Responders to Modafinil Treatment

Phase: N/A Priority: Normal
NCT ID: NCT00343811 Org: User:
Start: 06/30/06 End: 09/30/06 Due: 09/30/07

Open-Label Study to Determine the Maximum Tolerated Oral Dose of the Kinase Inhibitor CEP-11981 in Patients With Advanced Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00875264 Org: User:
Start: 09/30/07 End: 06/30/11 Due: 06/30/12

Study of the Efficacy, Safety and Tolerability of Oral CEP-701 in Patients With Severe Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT00236119 Org: User:
Start: 06/30/05 End: 10/31/07 Due: 10/31/08

Assess the Safety and Effectiveness of PROVIGIL Treatment in Children and Adolescents With Excessive Sleepiness

Phase: N/A Priority: Normal
NCT ID: NCT00214968 Org: User:
Start: 01/31/05 End: 10/31/05 Due: 10/31/06

Study of CEP-9722 as Single-Agent Therapy and as Combination Therapy With Temozolomide in Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00920595 Org: User:
Start: 06/30/09 End: 10/31/11 Due: 10/31/12

Study to Evaluate the Efficacy and Safety of ORAVESCENT Fentanyl Citrate for the Management of Breakthrough Pain

Phase: N/A Priority: Normal
NCT ID: NCT00214955 Org: User:
Start: 09/30/05 End: - Due: -

Open-Label Study of Oral CEP-701 (Lestaurtinib) in Patients With Polycythemia Vera or Essential Thrombocytosis

Phase: N/A Priority: Normal
NCT ID: NCT00586651 Org: User:
Start: 12/31/07 End: 09/30/10 Due: 09/30/11

Study to Evaluate the Safety and Efficacy of GABITRIL Treatment in Adults With Generalized Anxiety Disorder.

Phase: N/A Priority: Normal
NCT ID: NCT00214994 Org: User:
Start: 01/31/05 End: 12/31/06 Due: 12/31/07

Study of the Efficacy and Multiple-Dose Plasma Concentration-Time Profiles of Armodafinil and PROVIGIL

Phase: N/A Priority: Normal
NCT ID: NCT00236080 Org: User:
Start: 08/31/05 End: 12/31/05 Due: 12/31/06

Efficacy and Safety of Armodafinil for Adults With Excessive Sleepiness Obstructive Sleep Apnea/Hypopnea and Depression

Phase: N/A Priority: Normal
NCT ID: NCT00518986 Org: User:
Start: 10/31/07 End: 03/31/09 Due: 03/31/10